Issued Patents All Time
Showing 1–25 of 70 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12415809 | Pyrrolotriazine compounds as tam inhibitors | Yun-Long Li, Xiaozhao Wang, Joseph Barbosa, David M. Burns, Hao Feng +4 more | 2025-09-16 |
| 12201636 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Andrew P. Combs, Eddy W. Yue, Song Mei +2 more | 2025-01-21 |
| 12084430 | Tricyclic urea compounds as JAK2 V617F inhibitors | Cooper Taylor, Yanran Ai, Ke Zhang, Eddy W. Yue | 2024-09-10 |
| 12084449 | Imidazotriazines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Colin Zhang, Ding-Quan Qian, David M. Burns +3 more | 2024-09-10 |
| 12030889 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Jun Pan, Jeremy Roach, Song Mei, Liangxing Wu, Wenqing Yao | 2024-07-09 |
| 11840534 | Substituted tricyclic compounds as FGFR inhibitors | Liangxing Wu, Colin Zhang, Liang Lu, Wenqing Yao | 2023-12-12 |
| 11673894 | Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors | Xiaozhao Wang, Pei Gan, Taisheng Huang, Chao Qi, Ding-Quan Qian +5 more | 2023-06-13 |
| 11591338 | Pyrrolotriazine compounds as TAM inhibitors | Yun-Long Li, Xiaozhao Wang | 2023-02-28 |
| 11530214 | Bicyclic heterocycles as FGFR inhibitors | Liang Lu, Wenqing Yao, Fenglei Zhang | 2022-12-20 |
| 11459329 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Jun Pan, Jeremy Roach, Song Mei, Liangxing Wu, Wenqing Yao | 2022-10-04 |
| 11433071 | Heterocyclylamines as PI3K inhibitors | Yun-Long Li, Wenqing Yao, Andrew P. Combs, Eddy W. Yue, Song Mei +4 more | 2022-09-06 |
| 11401272 | Heterocyclic compounds as LSD1 inhibitors | Zhenwu Li, Liangxing Wu, Wenqing Yao, Fenglei Zhang | 2022-08-02 |
| 11261191 | Imidazotriaines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Colin Zhang, Ding-Quan Qian, David M. Burns +3 more | 2022-03-01 |
| 11247992 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Xiaozhao Wang, Wenqing Yao, Fenglei Zhang | 2022-02-15 |
| 11220510 | Pyrrole tricyclic compounds as A2A / A2B inhibitors | Xiaozhao Wang, Peter Carlsen, Taisheng Huang | 2022-01-11 |
| 11136326 | Pyrrolopyrimidine derivatives as TAM inhibitors | Yun-Long Li, David M. Burns, Hao Feng, Joseph Glenn, Song Mei +3 more | 2021-10-05 |
| 11053246 | Substituted tricyclic compounds as FGFR inhibitors | Liangxing Wu, Colin Zhang, Liang Lu, Wenqing Yao | 2021-07-06 |
| 10919901 | Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors | Jincong Zhuo, Wenqing Yao | 2021-02-16 |
| 10844069 | Pyrrolotriazine compounds as TAM inhibitors | Yun-Long Li, Xiaozhao Wang | 2020-11-24 |
| 10813930 | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 | Wenqing Yao, Colin Zhang, Meizhong Xu, Jincong Zhuo | 2020-10-27 |
| 10800779 | Heterocyclic compounds as LSD1 inhibitors | Zhenwu Li, Liangxing Wu, Wenqing Yao, Fenglei Zhang | 2020-10-13 |
| 10738052 | Imidazotriaines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Colin Zhang, Ding-Quan Qian, David M. Burns +3 more | 2020-08-11 |
| 10717737 | Cyclopropylamines as LSD1 inhibitors | Liangxing Wu, Wenqing Yao, Fenglei Zhang | 2020-07-21 |
| 10640503 | Imidazopyridines and imidazopyrazines as LSD1 inhibitors | Liangxing Wu, Leah C. Konkol, Neil Lajkiewicz, Liang Lu, Meizhong Xu +3 more | 2020-05-05 |
| 10556908 | Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors | Liangxing Wu, Joel R. Courter, Jingwei Li, Liang Lu, Yaping Sun +4 more | 2020-02-11 |